Phase II trial of irinotecan and cisplatin combination as first-line chemotherapy in patients with advanced esophageal squamous-cell carcinoma: An interim report

被引：1
|
作者：
Zhang, X.
Shen, L.
Li, J.
Li, Y.
Zhou, J.
Lu, Z.
Lu, M.
机构：
[1] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
[2] Peking Univ, Canc Hosp, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Apatinib and irinotecan combination treatment in first-line chemotherapy refractory esophageal squamous cell carcinoma: A phase I dose escalation study
    Jia, J.
    Yu, J.
    Sun, Z.
    Yang, Y.
    Liu, C.
    Xiao, Y.
    Zhang, X.
    ANNALS OF ONCOLOGY, 2017, 28
  • [12] Phase II trial of paclitaxel and cisplatin combination given biweekly as first-line chemotherapy in patients with advanced or metastatic squamous cell carcinoma of esophagus from a single center in China.
    Zhou, Y.
    Huang, J.
    Yang, L.
    Cai, G. R.
    Xu, H. B.
    Wang, W. J.
    Shi, K. Y.
    Sun, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [13] Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer
    Sugiyama, T
    Yakushiji, M
    Noda, K
    Ikeda, M
    Kudoh, R
    Yajima, A
    Tomoda, Y
    Terashima, Y
    Takeuchi, S
    Hiura, M
    Saji, F
    Takahashi, T
    Umesaki, N
    Sato, S
    Hatae, M
    Ohashi, Y
    ONCOLOGY, 2000, 58 (01) : 31 - 37
  • [14] Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma - A phase II trial
    Baur, M
    Kienzer, HR
    Schweiger, J
    DeSantis, M
    Gerber, E
    Pont, J
    Hudec, M
    Schratter-Sehn, AU
    Wicke, W
    Dittrich, C
    CANCER, 2002, 94 (11) : 2953 - 2958
  • [15] First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study
    Li, Jin
    Chen, Zhendong
    Bai, Yuxian
    Liu, Bo
    Li, Qingshan
    Zhang, Jingdong
    Zhou, Jun
    Deng, Ting
    Zhou, Fuyou
    Gao, Shegan
    Yang, Shujun
    Ye, Feng
    Chen, Long
    Bai, Wei
    Yin, Xianli
    Cang, Shundong
    Liu, Lianke
    Pan, Yueyin
    Luo, Hui
    Ji, Yanxia
    Zhang, Zhen
    Wang, Jufeng
    Yang, Quanliang
    Li, Na
    Huang, Rong
    Qu, Chenglin
    Ni, Jing
    Wang, Bo
    Xu, Yan
    Hu, Jin
    Shi, Qingmei
    Yang, Jason
    NATURE MEDICINE, 2024, 30 (03) : 740 - 748
  • [16] First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study
    Jin Li
    Zhendong Chen
    Yuxian Bai
    Bo Liu
    Qingshan Li
    Jingdong Zhang
    Jun Zhou
    Ting Deng
    Fuyou Zhou
    Shegan Gao
    Shujun Yang
    Feng Ye
    Long Chen
    Wei Bai
    Xianli Yin
    Shundong Cang
    Lianke Liu
    Yueyin Pan
    Hui Luo
    Yanxia Ji
    Zhen Zhang
    Jufeng Wang
    Quanliang Yang
    Na Li
    Rong Huang
    Chenglin Qu
    Jing Ni
    Bo Wang
    Yan Xu
    Jin Hu
    Qingmei Shi
    Jason Yang
    Nature Medicine, 2024, 30 : 740 - 748
  • [17] Phase II trial of cisplatin and Gemcitabine in advanced squamous-cell carcinoma of the head and neck
    Hitt, R
    Castellano, D
    Hidalgo, M
    García-Carbonero, R
    Peña, M
    Brandariz, A
    Millán, JM
    Vincent, JJA
    Cortés-Funes, H
    ANNALS OF ONCOLOGY, 1998, 9 (12) : 1347 - 1349
  • [18] CISPLATIN AND IFOSFAMIDE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX - A PHASE-II TRIAL
    CERVELLINO, JC
    ARAUJO, CE
    SANCHEZ, O
    MILES, H
    NISHIHAMA, A
    ACTA ONCOLOGICA, 1995, 34 (02) : 257 - 259
  • [19] Cost-effectiveness analysis of nivolumab combination therapy in the first-line treatment for advanced esophageal squamous-cell carcinoma
    Liu, Shixian
    Dou, Lei
    Wang, Kaixuan
    Shi, Zhao
    Wang, Ruixue
    Zhu, Xiaohong
    Song, Zehua
    Li, Shunping
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [20] Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma
    Mok, Tony
    Yang, Tsai-Shen
    Chao, Yee
    Wang, Cheng-Hsu
    Liu, Mei-Ching
    Kang, Yoon Koo
    Kang, Won Ki
    Kim, Jun Suk
    Wang, Yajie
    Leung, Thomas
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (02) : 95 - 100
12345